SNWV Stock Analysis: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$26.64
-0.32 (-1.19%)
▼
5d:
-1.95%
30d:
-10.72%
90d:
-4.93%
HOLD
MODERATE Confidence
Last Updated: February 2, 2026
Earnings: Mar 19, 2026
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNWV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNWV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.27
Based on 11.5% avg growth
INTRINSIC VALUE TODAY
$25.00
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $26.64, which is considered oversold relative to its 30-day fair value range of $26.94 to $29.94. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.3) compared to its historical average (32.0). Remarkably, the market is currently pricing in an annual earnings decline of 4.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNWV is in a downtrend. The price is currently testing key support at $26.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNWV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $54.00 (+102.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNWV is in a downtrend. The price is currently testing key support at $26.10. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SNWV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $54.00 (+102.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$26.94 -
$29.94
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 102.7% below Wall St target ($54.00)
Fair Price Analysis
30-Day Fair Range
$26.94 -
$29.94
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$26.10
Resistance Level
$28.60
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
28.34
Wall Street Target
$54.00
(+102.7%)
Revenue Growth (YoY)
22.3%
Earnings Growth (YoY)
-99.6%
Profit Margin
-17.1%
Valuation Discount vs History
-4.0% cheaper
PE vs Historical
28.3 vs 32.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.0%
(market-implied from PE analysis)
1-Year Target
$25.57
(-4%)
2-Year Target
$24.55
(-8%)
3-Year Target
$23.57
(-12%)
3-Yr Target (if PE normalizes)
(PE: 28→32)
$26.61
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.3, Growth: 19.0%)
$44.88
(+69%)
Base:
(SPY PE: 22.3, Growth: 19.0%)
$35.31
(+33%)
Bear:
(PE: 19.0, Growth: 19.0%)
$30.02
(+13%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.3 to 32.0
Stabilization Target:
$30.08
(+12.9%)
PE Expansion Potential:
+12.9%
Last updated: February 03, 2026 7:31 AM ET
Data refreshes hourly during market hours. Next update: 8:31 AM
Data refreshes hourly during market hours. Next update: 8:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 69 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 59 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 59 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 57 HOLD |
